Skip to content
Clinical Trials – home

Newderm Clinic S.R.L.

Research site

Romania Strada Martir Paris Janos 11, 300757 Timisoara, Romania

  • Psoriasis · Dermatitis atopic
  • Adult patients

About Specializations

Newderm Clinic S.R.L. in Timisoara, Romania specialises in clinical trials of conditions such as Psoriasis, Dermatitis atopic, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology Research at Newderm Clinic S.R.L.

Clinical trial activity at Newderm Clinic S.R.L. focuses on skin and connective tissue diseases and immune system diseases, with studies centered on atopic dermatitis and moderate to severe plaque psoriasis. The research is aimed at understanding how new treatments perform and how they compare with existing options in people living with chronic inflammatory skin conditions.

  • Evaluating new treatment options for atopic dermatitis to see how well they reduce symptoms and improve disease control.
  • Comparing investigational therapies for moderate to severe plaque psoriasis against placebo and established treatments to measure effectiveness.
  • Studying the long-term safety of psoriasis therapies, with attention to cardiovascular safety and overall treatment tolerability.

This dermatology site in Timisoara contributes to research that may help refine treatment choices for patients with persistent inflammatory skin disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Martir Paris Janos 11300757 TimisoaraRomania
Recruiting now
no trials
Conditions studied
2

More sites in TimisoaraRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Psoriasis

Not yet recruiting

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen Cilag International

Dermatitis atopic

Not recruiting

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
  • Sponsor:Leo Pharma A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.